Answers are grounded in this paper and cite their sources.
Randomized controlled trial shows unani formulations improve clinical outcomes and inflammatory biomarkers in COVID-19 patients, suggesting potential for broader applications.
Background: This randomized controlled study aimed to evaluate the efficacy of a test drug on clinical outcomes and inflammatory biomarkers in COVID-19 patients. Methodology: A total of 93 patients were screened, and 84 met the inclusion criteria. Participants were randomized into two groups: test Group A ( n = 41) and control Group B ( n = 43). After accounting for dropouts, 40 patients from each group completed the protocol therapy. The mean age of participants was 40.55 ± 2.096 years in Group A and 39.75 ± 1.944 years in Group B. Results: Significant reductions in inflammatory markers were observed in both groups, with greater improvements in the test group. In Group A, C-reactive protein (CRP) levels decreased from 14.133 ± 4.361 to 6.779 ± 1.331, while in Group B, CRP levels decreased from 17.5504 ± 4.281 to 4.0236 ± 0.9165. Serum ferritin and D-dimer levels also showed substantial reductions, with Group A achieving statistically significant improvements ( P < 0.0001 for ferritin and P = 0.0117 for D-dimer). Although lactate dehydrogenase and immunoglobulin-G levels showed favorable trends, the changes were not statistically significant. interleukin-6 levels decreased significantly in Group A, suggesting that the test drug may help prevent cytokine storms. Conclusion: The test drug demonstrated efficacy in modulating inflammatory responses and improving clinical outcomes in COVID-19 patients. Its immune-modulatory and anti-inflammatory properties, as highlighted in classical Unani literature, likely contributed to these effects. Further large-scale studies are needed to confirm these findings and explore broader applications of the test drugs.
No takes yet. Share an insight, caveat, or question.
Fatima et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: